RESUMO
BACKGROUND: Skin cancer is the most common malignancy and can be treated in various ways. One treatment modality is Mohs micrographic surgery. Due to the increasing incidence of skin cancer in the last decades, there is a need for improvement of the Mohs technique to optimize its effectiveness. OBJECTIVE: The aim of this study was to evaluate the use of dermoscopy to guide demarcation of Mohs micrographic surgery margins and ascertain whether this method can reduce operative time and, therefore, reduce surgical morbidity and cost. METHODS AND MATERIALS: The sample comprised 44 patients who underwent Mohs micrographic surgery, allocated into two groups: the control group and the intervention group. In the latter, surgical margins were guided by dermoscopy. RESULTS: There were no statistically significant differences between the two groups by chi-square analysis (p = 0.399). CONCLUSION: Although outcomes were similar in the two groups, demonstrating that dermoscopy does not help in the demarcation of surgical margins for Mohs micrographic surgery, the study provides a practical proposal for improvement of the Mohs technique.
Assuntos
Carcinoma/cirurgia , Dermoscopia/métodos , Cirurgia de Mohs/métodos , Neoplasias Cutâneas/cirurgia , Pontos de Referência Anatômicos , Carcinoma/economia , Carcinoma/patologia , Carcinoma Basocelular/economia , Carcinoma Basocelular/patologia , Carcinoma Basocelular/cirurgia , Distribuição de Qui-Quadrado , Dermoscopia/economia , Feminino , Humanos , Masculino , Cirurgia de Mohs/economia , Duração da Cirurgia , Estudos Prospectivos , Reprodutibilidade dos Testes , Neoplasias Cutâneas/economia , Neoplasias Cutâneas/patologia , Resultado do TratamentoRESUMO
BACKGROUND: Skin cancer is the most common malignancy and can be treated in various ways. One treatment modality is Mohs micrographic surgery. Due to the increasing incidence of skin cancer in the last decades, there is a need for improvement of the Mohs technique to optimize its effectiveness. OBJECTIVE: The aim of this study was to evaluate the use of dermoscopy to guide demarcation of Mohs micrographic surgery margins and ascertain whether this method can reduce operative time and, therefore, reduce surgical morbidity and cost. METHODS AND MATERIALS: The sample comprised 44 patients who underwent Mohs micrographic surgery, allocated into two groups: the control group and the intervention group. In the latter, surgical margins were guided by dermoscopy. RESULTS: There were no statistically significant differences between the two groups by chi-square analysis (p = 0.399). CONCLUSION: Although outcomes were similar in the two groups, demonstrating that dermoscopy does not help in the demarcation of surgical margins for Mohs micrographic surgery, the study provides a practical proposal for improvement of the Mohs technique. .
Assuntos
Feminino , Humanos , Masculino , Carcinoma/cirurgia , Dermoscopia/métodos , Cirurgia de Mohs/métodos , Neoplasias Cutâneas/cirurgia , Pontos de Referência Anatômicos , Distribuição de Qui-Quadrado , Carcinoma Basocelular/economia , Carcinoma Basocelular/patologia , Carcinoma Basocelular/cirurgia , Carcinoma/economia , Carcinoma/patologia , Dermoscopia/economia , Cirurgia de Mohs/economia , Duração da Cirurgia , Estudos Prospectivos , Reprodutibilidade dos Testes , Neoplasias Cutâneas/economia , Neoplasias Cutâneas/patologia , Resultado do TratamentoRESUMO
BACKGROUND: Little is known about costs associated with differentiated thyroid cancer (DTC) and follow-up care. This study used data from the Surveillance Epidemiology and End Results (SEER) database to examine cumulative costs attributable to disease stage and treatment options of DTC in elderly patients over 5 years. METHODS: We identified 2,823 patients aged >65 years with DTC and 5,646 noncancer comparison cases from SEER Medicare data between 1995 and 2005. Cumulative costs were obtained by estimating average costs/patient in each month up to 60 months after diagnosis. We performed multivariate analyses of costs by fitting each monthly cost to linear models, controlling for demographics and comorbidities. Marginal effects of covariates were obtained by summing coefficients over 60 months. RESULTS: Cumulative costs were $17,669/patient the first year and $48,989/patient 5 years after diagnosis. Regional disease was associated with higher costs at 1 year ($9,578) and 5 years ($8,902). Distant disease was associated with 1-year costs of $28,447 and 5-year costs of $20,103. Patients undergoing surgery and radiation had a decrease in cost of $722 at 5 years. CONCLUSION: DTC in the elderly is associated with significant economic burden largely attributable to patient demographics, stage of disease, and treatment modalities.
Assuntos
Neoplasias da Glândula Tireoide/economia , Adenocarcinoma Folicular/economia , Adenocarcinoma Folicular/patologia , Adenocarcinoma Folicular/terapia , Idoso , Idoso de 80 Anos ou mais , Carcinoma/economia , Carcinoma/patologia , Carcinoma/terapia , Carcinoma Papilar/economia , Carcinoma Papilar/patologia , Carcinoma Papilar/terapia , Feminino , Custos de Cuidados de Saúde , Humanos , Masculino , Medicare , Programa de SEER , Câncer Papilífero da Tireoide , Neoplasias da Glândula Tireoide/patologia , Neoplasias da Glândula Tireoide/terapia , Estados UnidosRESUMO
BACKGROUND: Chest X ray, abdominal ultrasound and bone scintigraphy are usually requested to study a possible dissemination of breast carcinoma. AIM: To study the yield and costs of these exams in the study of dissemination of stage I and II breast carcinoma. MATERIAL AND METHODS: A retrospective analysis of patients operated for a breast carcinoma in a public surgical service. A chest X ray, abdominal ultrasound and bone scintigraphy was requested to all patients in the immediate postoperative period. Age, stage according to pathological TNM and costs per patient were registered. RESULTS: Of 210 women operated, 40 were in stage I (19%) and 85 in stage II (41%). Dissemination study was negative in all stage I patients and in all but two patients in stage II. The yield for detection of distant metastases in these patients was 0.9% for chest X ray, 0% for abdominal ultrasound and 0.9% for bone scintigraphy. The total cost of the study, in Chilean pesos, was $10,369,620 in a public hospital and $16,535,400 in a private clinic. DISCUSSION: Additional exams to detect distant metastases in early stages of breast carcinoma have a low yield and high costs.